Patent · US Active

Method for evaluating the risk of mortality in patients who exhibit a systemic inflammatory response syndrome (SIRS) or sepsis

US10663472B2 · kind B2 · utility

0Cited by
1References
3Claims
0Family size

Assignees

Inventors

Key dates

Filing dateSep 18, 2014
Grant dateMay 26, 2020
Priority date
Expiry dateDec 24, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/26
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The invention provides a method of evaluating the risk of mortality in patients who present a systemic inflammatory response (SIRS) or septic syndromes, comprising measuring the expression of sCD127 in a biological sample.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.